Canada - English - Health Canada

homeocan inc. - stannic iodide - tablet - 3ch - stannic iodide 3ch - homeopathic products

Canada - English - Health Canada

biocentre - ferrous phosphate; ferric hydroxide; ferric nitrate; stannic iodide - tablet - 12x; 3x; 6x; 3x - ferrous phosphate 12x; ferric hydroxide 3x; ferric nitrate 6x; stannic iodide 3x - homeopathic products

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - stannic hydrogen phosphate (unii: m4j84t83qf) (stannic cation - unii:xpm618y22p) -

Singapore - English - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - bicisate dihydrochloride (ecd.2hcl) (in vial a- ligand)) - injection, powder, for solution - 0.9 mg/vial - bicisate dihydrochloride (ecd.2hcl) (in vial a- ligand)) 0.9 mg/vial

United States - English - NLM (National Library of Medicine)

bracco diagnostics inc - rubidium chloride rb-82 (unii: f0z746krkq) (rubidium cation rb-82 - unii:550z839889) - rubidium cation rb-82 150 mci - cardiogen-82 is a closed system used to produce rubidium rb 82 chloride injection for intravenous administration. rubidium rb 82 chloride injection is indicated for positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. cardiogen-82 is contraindicated if a solution other than additive free 0.9% sodium chloride injection usp has been used to elute the generator at any time. immediately stop the patient infusion and permanently discontinue the use of the affected cardiogen-82 generator whenever the incorrect eluent is used [see boxed warning, contraindications (4), and warnings and precautions (5.1)] risk summary there are no data available on the use of rubidium rb 82 chloride in pregnant women. animal reproductive studies have not been conducted with rubidium rb 82 chloride injection. however, all radiopharmaceuticals have the potential to cause fe

United States - English - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - rubidium chloride rb-82 (unii: f0z746krkq) (rubidium cation rb-82 - unii:550z839889) - rubidium cation rb-82 100 mci - ruby-fill is a closed system used to produce rubidium rb 82 chloride injection for intravenous administration. rubidium rb 82 chloride injection is indicated for positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. ruby-fill is contraindicated for use if a solution other than additive-free 0.9% sodium chloride injection usp has been used to elute the generator at any time. immediately stop the patient infusion and permanently discontinue the use of the affected ruby-fill generator whenever the incorrect eluent is used [see boxed warning, contraindications (4), warnings and precautions (5.1) ]. risk summary there are no data available on the use of rubidium rb 82 in pregnant women. animal reproduction studies with rubidium rb 82 chloride have not been conducted. however, all radiopharmaceuticals have the potential to cause fetal harm depending

United States - English - NLM (National Library of Medicine)

curium us llc - oxidronate disodium (unii: h852yk87wp) (oxidronic acid - unii:71mr4v32ti) - oxidronate disodium 3.15 mg - technescan hdp tc 99m is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients. none known. all procedures should be conducted using waterproof gloves. use shielded syringe during transport and administration of tc 99m solutions. - remove plastic disc from technescan hdp vial and cleanse top by swabbing with alcohol. note: if dose is for a single adult patient or for a pediatric patient, see unit dose preparation method below. - place vial in lead vial shield. add 3 to 6 ml of sodium pertechnetate tc 99m solution and secure with a fitted lead cover. in choosing the amount of tc 99m radioactivity to be used, the number of doses desired, the activity of each dose [recommended adult dose is 555 mbq (15 mci) with a range of 370 to 740 mbq (10 to 20 mci)] and radioactive decay must be taken into account. the recommended maximum amount of tc 99m radioactivity to be added to the vial is 11.1 gigabecquerels (300 mci). note: the contents of the vial are

Australia - English - Department of Health (Therapeutic Goods Administration)

sndr pty ltd - homosalate, quantity: 100 mg/g; octocrylene, quantity: 80 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g - spray - excipient ingredients: light liquid paraffin; isopropyl palmitate; isostearyl neopentanoate; colloidal anhydrous silica; coconut oil; almond oil; simmondsia chinensis; dl-alpha-tocopheryl acetate; butylated hydroxytoluene; iron oxide yellow; iron oxide red; iron oxide black; mica; titanium dioxide; stannic oxide; theobroma oil; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

grace & fire pty ltd - homosalate, quantity: 100 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g; octocrylene, quantity: 80 mg/g; octyl salicylate, quantity: 50 mg/g - lotion - excipient ingredients: stannic oxide; citric acid; aloe vera; sodium citrate; trolamine; mica; phenoxyethanol; purified water; saccharide isomerate; titanium dioxide; hydroxyacetophenone; benzyl alcohol; maltodextrin; white beeswax; isopropyl palmitate; dl-alpha-tocopheryl acetate; sodium stearoyl glutamate; ceteareth-20; cetostearyl alcohol; carbomer 941; cyclomethicone; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

concept laboratories pty ltd - zinc oxide, quantity: 216 mg/g - lotion - excipient ingredients: lavender oil; geranium oil; rubus idaeus; rosa canina; camellia sinensis; purified water; medium chain triglycerides; glyceryl isostearate; polyhydroxystearic acid; triethoxycaprylylsilane; caprylyl glycol; phenethyl alcohol; potassium sorbate; iron oxide yellow; iron oxide red; iron oxide black; silicon dioxide; mica; titanium dioxide; stannic oxide; citric acid; saccharide isomerate; sodium citrate; xanthan gum; cucumis sativus; safflower oil; isoamyl laurate; cetearyl glucoside; cetostearyl alcohol; sucrose cocoate; sorbitan monostearate; hydroxypropyl distarch phosphate - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)